LYPSYL Extreme Cold Sore Relief
Natural health product licensed in Canada
- Licence holder
- LPNA Group, Inc. d/b/a Lornamead Products
- NPN or DIN-HM
- 80144997
- Status
- Active licence
- Licence date
- 27 October 2025
- Revision date
- Not provided
- Form
- Crème
- Route of administration
- Topique
- Application type
- Générale (non traditionelle)
Oral dose analysis does not apply without an established exclusively oral route.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source |
|---|---|
| l-Menthol Source : Mentha X piperita - feuille | 0.7 % |
Non-medicinal ingredients
Palmitate d'ascorbyle, Huile de Mentha piperita (Menthe poivrée), Copolymère de butylène/éthylène/styrène, d-camphre, Copolymère d'éthylène/propylène/styrène, Beurre de Butyrospermum Parkii (Karité), Diméthicone, Polyisobutène, Lactate de zinc, Cire d'abeille, Dioxyde de titane, Extrait de Melaleuca alternifolia (Arbre à thé), Acétate de dl-alpha tocophéryle, Lysine, Poly(isobutène) hydrogéné, (p)-hydroxybenzoate de propyle, Extrait de feuilles d'Aloe barbadensis, Extrait de feuilles d'Eucalyptus globulus, Pétrolatum, Extrait de Chamomilla recutita (Matricaire camomille), Extrait de Lavandula Angustifolia (Lavande), Allantoïne, Tétracaprylate/Tétracaprate de pentaérythrityle
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes et enfants | minimum: 12 years | Not specified | Not specified |
Uses authorised in Canada
Text supplied in English because no French text is available.
For the temporary relief of pain associated with cold sores & fever blisters.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Source
Official Health Canada record, licence 80144997
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.